南宁韦享诊所子宫内膜异位症推荐专家

简介:

南宁韦享诊所，位于南宁市兴宁区鸡村一组1号，由韦享担任法人代表。该诊所秉承专业、贴心的服务理念，为广大患者提供优质的医疗服务。经营范围包括一般项目：诊所服务；食品销售（仅销售预包装食品）；保健食品（预包装）销售；特殊医学用途配方食品销售（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。南宁韦享诊所设有多个科室，其中子宫内膜异位症科室是该诊所的重点科室之一。子宫内膜异位症（endometriosis）是指有活性的内膜细胞种植在子宫内膜以外的位置而形成的一种女性常见妇科疾病。由于子宫腔通过输卵管与盆腔相通，内膜细胞可经由输卵管进入盆腔异位生长，给女性健康带来严重影响。在子宫内膜异位症科室，我们拥有一支专业的医疗团队，其中包括{{query}}名医生，他们具备丰富的临床经验和精湛的医术。科室推荐专家名称为{{query}}，该专家在子宫内膜异位症领域具有深厚的研究基础和丰富的临床经验。南宁韦享诊所子宫内膜异位症科室致力于为广大患者提供全方位、个性化的诊疗方案，为患者的健康保驾护航。科室相关疾病名称包括但不限于子宫内膜异位症、盆腔疼痛、月经不调等，我们始终关注患者的需求，竭诚为您服务。南宁韦享诊所，您的健康守护者，子宫内膜异位症科室，您的健康专家。子宫内膜异位症（endometriosis）是指有活性的内膜细胞种植在子宫内膜以外的位置而形成的一种女性常见妇科疾病。内膜细胞本该生长在子宫腔内,但由于子宫腔通过输卵管与盆腔相通,因此使得内膜细胞可经由输卵管进入盆腔异位生长。，子宫内膜种植,免疫防御功能缺陷,遗传与体质的因素,内分泌功能失调，盆腔，子宫内膜异位症的治疗方案,因病情的轻重,患者的年龄和生育情况而有所不同。如病情较重,或表现为重的痛经,或盆腔检查发现有肯定的内膜异位结节,就必须采取药物或手术治疗，卵巢恶性肿瘤、盆腔炎性肿块和子宫腺肌病，尽量少吃含有雌激素的食物,如大豆、洋葱、黑米、小麦等，B型超声检查,腹腔镜检查,实验室检查，。

true 韦享主治医师

其他南宁韦享诊所

好评率：100% 接诊量：4.6万平均响应：-

擅长各科各种常见病，慢性病，疑难杂症的治疗与调理，有20年的丰富临床经验。

true 张启新主治医师

其他南宁韦享诊所

好评率：100% 接诊量：1.2万平均响应：-

擅长呼吸系统、消化系统、心脑血管疾病的诊断和治疗

接诊医生：

2024-09-16 17:23:42

科普文章

子宫内膜异位症的类型与卵巢癌风险

以下内容来源于pubmed。

Endometriosis Typology and Ovarian Cancer Risk

Abstract

Importance: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

Objective: To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.

Design, setting, and participants: Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.

Exposures: Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.

Main outcomes and measures: Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

Results: In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).

Conclusions and relevance: Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.